Skip to main content

Featured post

Marketers Will Pay Naira for Dangote Fuel -IPMAN

Aliko Dangote Refined petroleum products from the $20bn Dangote Petroleum Refinery are to be sold in naira and not in the United States dollar as speculated in some quarters, oil marketers clarified on Monday. Dealers in the downstream oil sector also stated that the registration process for marketers at the refinery was still ongoing, as many operators had continued to register with the plant. It was further gathered that officials of the Nigerian Midstream and Downstream Petroleum Regulatory Authority were meeting with the management of the refinery to perfect the pricing template for products produced by the facility. On January 12, 2023, the Dangote Petroleum Refinery announced the commencement of production of Automotive Gas Oil, also known as diesel, and JetA1 or aviation fuel. The President, Dangote Group, Aliko Dangote, had in a statement issued by the firm, said, “We have started the production of diesel and aviation fuel, and the products will be in the market within this mon...
Post a Comment
Read more
Labels

Health: FDA Adds Rare Neurological Syndrome Warning to Johnson & Johnson COVID-19 Vaccine

Guillain-Barre syndrome is a rare disorder in which the body’s immune system attacks the nerves.


The Associated Press

A health worker prepares a dose of the Johnson & Johnson COVID-19 vaccine at a vaccination site in Philadelphia, in March.The Associated Press

The Johnson & Johnson COVID-19 vaccine label now includes a warning about a possible increased risk of a rare disorder known as Guillain-Barre syndrome.

The Food and Drug Administration on Monday changed the label to note that "reports of adverse events following use of the Janssen COVID-19 Vaccine under emergency use authorization suggest an increased risk of Guillain-Barré syndrome during the 42 days following vaccination."

Guillain-Barre syndrome is a rare complication in which the body's immune system attacks the nerves. Symptoms include tingling and weakness in the extremities. Symptoms usually resolve within weeks, but some cases can cause permanent nerve damage.

Around 100 preliminary reports of the syndrome have been detected in the Vaccine Adverse Event Reporting System out of 12.8 million doses of the J&J vaccine administered, according to the Centers for Disease Control and Prevention.

"These cases have largely been reported about two weeks after vaccination and mostly in males, many aged 50 years and older," the CDC said in a statement, adding that the topic will be discussed in an upcoming meeting of the agency's vaccine advisory committee.

Data does not show a similar trend in the Pfizer or Moderna coronavirus vaccines, according to CDC. It's the latest setback for the J&J vaccine, which was temporarily paused earlier this year as federal officials investigated a small number of rare and severe blood clots in people who received the shot.

Between 3,000 and 6,000 people in the U.S. typically develop Guillain-Barre syndrome each year, according to the CDC. The exact cause is unknown, though it is usually triggered after a respiratory or gastrointestinal infection.


Source

Email Post
Labels:

Comments

Post a Comment